Patent · US Expired

Pharmaceutical composition for oral administration of a N-piperidino-3- pyrazolecarboxamide derivative, its salts and their solvates

US6893659B2 · kind B2 · utility

5Cited by
4References
13Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 1, 2002
Grant dateMay 17, 2005
Priority date
Expiry dateMay 1, 2022

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K9/4866
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The pharmaceutical compositions for oral administration according to the invention contain 0.5% to 20% of N-piperidino-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methylpyrazole-3-carboxamide in microcrystalline form, and pharmaceutical excipients; they are formulated by wet granulation.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.